Epidermolysis bullosa (EB) - diagnosis and therapy

被引:0
|
作者
McMillan, J. R. [1 ]
Ha, Long [2 ]
Akiyama, M. [2 ]
Shimizu, H. [2 ]
Kimble, R. M. [3 ]
机构
[1] Univ Queensland, Royal Childrens Hosp, Burns Lab Res, Burns & Trauma Res Grp,Paediat & Child Hlth, L-3 RCH Fdn Bldg, Herston, Qld 4029, Australia
[2] Hokkaido Univ, Dept Dermatol, Grad Sch Med, Sapporo, Hokkaido, Japan
[3] Univ Queensland, Royal Childrens Hosp, Burns & Trauma Res Grp, Brisbane, Qld, Australia
来源
WOUND PRACTICE AND RESEARCH | 2009年 / 17卷 / 02期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The hemidesmosome (HD)-anchoring filament complex comprises a multiprotein complex that aids the attachment of epidermal keratinocytes to the underlying basal lamina and dermis. The importance of the HD and its components is highlighted by genetic defects that cause congenital blistering skin diseases that are categorised under the epidermolysis bullosa (EB) group of disorders. EB disorders can be subcategorised into three main subtypes by the level of epidermal separation - within the basal keratinocyte (EB simplex - EBS), between the keratinocyte and underlying basal lamina (junctional EB - JEB), and separation beneath the basal lamina (dystrophic EB - DEB). HD-anchoring filament-related components - including keratins 5 and 14, plectin, alpha 6 beta 4 integrin, collagen XVII, laminin 332 and collagen VII - have been demonstrated to harbour defects leading to EB disease. We summarise here the current understanding of the biological function of these HD-components and their involvement in EB in light of their functions in keratinocyte adhesion and also describe putative future therapeutic avenues that hold promise to alleviate the morbidity suffered by EB patients over the coming decades.
引用
收藏
页码:62 / 70
页数:9
相关论文
共 50 条
  • [31] Raising the roof on epidermolysis bullosa (EB): a focus on new therapies
    Kopecki, Z.
    Murrell, D. F.
    Cowin, A. J.
    [J]. WOUND PRACTICE AND RESEARCH, 2009, 17 (02): : 76 - 82
  • [32] Histopathological diagnosis of inherited epidermolysis bullosa
    Leclerc-Mercier, S.
    Fraitag, S.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 (11): : 782 - 787
  • [33] Immunohistochemistry in epidermolysis bullosa diagnosis - Reply
    Bergman, R
    Petronius, D
    Sprecher, E
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2004, 26 (01) : 84 - 84
  • [34] A CASE FOR DIAGNOSIS (ACQUIRED EPIDERMOLYSIS BULLOSA)
    HALL, AF
    [J]. ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1948, 58 (05): : 570 - 570
  • [35] PHENYTOIN THERAPY OF RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (EPIDERMOLYSIS BULLOSA DYSTROPHICA HALLOPEAU-SIEMENS AND EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA)
    WIRTH, H
    NESCH, A
    OSTAPOWICZ, B
    ANTONLAMPRECHT, I
    [J]. ZEITSCHRIFT FUR HAUTKRANKHEITEN H&G, 1983, 58 (08): : 555 - &
  • [36] EB PATIENTS NEED EB SPECIALIZED SURGEONS: THE ROLE OF PAEDIATRIC SURGEONS IN EPIDERMOLYSIS BULLOSA
    Delgado-Miguel, Carlos
    Miguel-Ferrero, Miriam
    Munoz-Serrano, Antonio J.
    Leal, Nuria
    Triana, Paloma
    Lopez-Gutierrez, Juan Carlos
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 67 - 67
  • [37] Epidermolysis bullosa hereditariaHereditary epidermolysis bullosa
    M. Laimer
    C.M. Lanschützer
    E. Nischler
    A. Klausegger
    A. Diem
    G. Pohla-Gubo
    J.W. Bauer
    H. Hintner
    [J]. Monatsschrift Kinderheilkunde Zeitschrift für Kinder- und Jugendmedizin, 2008, 156 (2): : 110 - 121
  • [38] PHENYTOIN THERAPY FOR JUNCTIONAL EPIDERMOLYSIS BULLOSA
    ROGERS, RB
    YANCEY, KB
    ALLEN, BS
    GUILL, MF
    [J]. ARCHIVES OF DERMATOLOGY, 1983, 119 (11) : 925 - 926
  • [39] Towards gene therapy of epidermolysis bullosa
    Gagnoux, L
    Vailly, J
    Wagner, E
    Ortonne, JP
    Meneguzzi, G
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 9 - 9
  • [40] Gene therapy of junctional epidermolysis bullosa
    Kahn, Axel
    [J]. M S-MEDECINE SCIENCES, 2007, 23 (01): : 109 - 110